Treatment results and outcome in elderly patients with glioblastoma multiforme - A retrospective single institution analysis

被引:31
作者
Hoffermann, Markus [1 ]
Bruckmann, Lukas [1 ]
Ali, Kariem Mandy [1 ]
Asslaber, Martin [2 ]
Payer, Franz [3 ]
von Campe, Gord [1 ]
机构
[1] Med Univ Graz, Dept Neurosurg, A-8036 Graz, Austria
[2] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria
[3] Med Univ Graz, Dept Neurol, A-8036 Graz, Austria
关键词
Elderly; Extent of resection; Glioblastoma; Malignant Primary Brain Tumors; Temozolomide; HIGH-GRADE GLIOMAS; NEWLY-DIAGNOSED GLIOBLASTOMA; SURVIVAL CLINICAL ARTICLE; QUALITY-OF-LIFE; RADIOTHERAPY PLUS CONCOMITANT; GROSS-TOTAL RESECTION; ADJUVANT TEMOZOLOMIDE; RADIATION-THERAPY; PROGNOSTIC-FACTORS; MALIGNANT GLIOMAS;
D O I
10.1016/j.clineuro.2014.11.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Although glioblastoma multiforme is more common in patients older than 65 years, the elderly population is often excluded from clinical studies. Decision making in this subgroup can be challenging due to the lack of evidence for different neurosurgical and adjuvant treatment strategies. Methods: In this retrospective study, we evaluated clinical, treatment and survival data of 124 consecutive patients over 65 years of age with supratentorial glioblastoma multiforme. Results: Median OS was 6.0 months (std. error 0.783, 95% CI 4.456-7.535). Mean OS was 9.7 months (std. error 0.830,95% CI 8.073-11.327). In univariate regression analysis, low KPS was of negative prognostic value (p<0.006 for KPS <= 80), while greater advanced age did not have any impact on survival (p = 0.591 for differences between groups). Gross total resection and subtotal resection led to significantly improved overall survival (median 15.0 and 11.0 months: p<0.02) compared to partial resection or biopsy (both 4.0 months), but complications were more common in subtotal and partial resections. The last observation did not reach statistical significance (p = 0.06). Combinations of irradiation and Temozolomide chemotherapy proved to be more effective than other adjuvant therapies. Extent of resection (gross total resection vs. all others) and form of adjuvant treatment were the only factors of independent prognostic value in multivariate analysis (p = 0.031 and p<0.001, respectively). Conclusions: It appears that more aggressive treatment regimens can lead to longer overall survival in elderly glioblastoma multiforme patients. Gross total resection should be offered whenever safely possible; otherwise, biopsy may be preferred. Non-surgical treatment should consist of postoperative radiotherapy and concomitant and/or adjuvant chemotherapy. Possibly higher rates of hematological side effects in concomitant chemotherapy need to be further investigated. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 95 条
[1]   Treatment outcome and prognostic factors of adult glioblastoma multiforme [J].
Ahmadloo, Niloofar ;
Kani, Amir-Abbas ;
Mohammadianpanah, Mohammad ;
Nasrolahi, Hamid ;
Omidvari, Shapour ;
Mosalaei, Ahmad ;
Ansari, Mansour .
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (01) :21-30
[2]   Prognostic significance of MRP5 immunohistochemical expression in glioblastoma [J].
Alexiou, George A. ;
Goussia, Anna ;
Voulgaris, Spyridon ;
Fotopoulos, Andreas D. ;
Fotakopoulos, George ;
Ntoulia, Antigoni ;
Zikou, Anastasia ;
Tsekeris, Perikles ;
Argyropoulou, Maria I. ;
Kyritsis, Athanasios P. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) :1387-1391
[3]   Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma [J].
Barker, Christopher A. ;
Chang, Maria ;
Chou, Joanne F. ;
Zhang, Zhigang ;
Beal, Kathryn ;
Gutin, Philip H. ;
Iwamoto, Fabio M. .
JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) :391-397
[4]   Radiation response and survival time in patients with glioblastoma multiforme [J].
Barker, FG ;
Prados, MD ;
Chang, SM ;
Gutin, PH ;
Lamborn, KR ;
Larson, DA ;
Malec, MK ;
McDermott, MW ;
Sneed, PK ;
Wara, WM ;
Wilson, CB .
JOURNAL OF NEUROSURGERY, 1996, 84 (03) :442-448
[5]   Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients [J].
Behm, Timo ;
Horowski, Antonia ;
Schneider, Simon ;
Bock, Hans Christoph ;
Mielke, Dorothee ;
Rohde, Veit ;
Stockhammer, Florian .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (10) :2142-2146
[6]   Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article [J].
Bloch, Orin ;
Han, Seunggu J. ;
Cha, Soonmee ;
Sun, Matthew Z. ;
Aghi, Manish K. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Parsa, Andrew T. .
JOURNAL OF NEUROSURGERY, 2012, 117 (06) :1032-1038
[7]   Treatment decisions in elderly patients with glioblastoma [J].
Brandes, Alba A. ;
Bartolotti, Marco .
NATURE REVIEWS NEUROLOGY, 2012, 8 (12) :664-665
[8]   A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: The impact of the extent of resection on quality of life and survival [J].
Brown, PD ;
Maurer, MJ ;
Rummans, TA ;
Pollock, BE ;
Ballman, KV ;
Sloan, JA ;
Boeve, BF ;
Arusell, RM ;
Clark, MM ;
Buckner, JC .
NEUROSURGERY, 2005, 57 (03) :495-503
[9]  
Buckner JC, 2001, CANCER-AM CANCER SOC, V92, P420, DOI 10.1002/1097-0142(20010715)92:2<420::AID-CNCR1338>3.0.CO
[10]  
2-3